A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Universitaire Ziekenhuizen KU Leuven
H. Lee Moffitt Cancer Center and Research Institute
Regeneron Pharmaceuticals
Pfizer
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Iovance Biotherapeutics, Inc.
University of Utah
University of Thessaly
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
Pfizer
Obsidian Therapeutics, Inc.
Merck Sharp & Dohme LLC
Institute of Health Information and Statistics of the Czech Republic
CivaTech Oncology
Immorna Biotherapeutics, Inc.
University of Southern California
M.D. Anderson Cancer Center
Rhode Island Hospital
Klein Buendel, Inc.
University Hospital Augsburg
Filamon LTD
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pfizer
Bristol-Myers Squibb
Ankyra Therapeutics, Inc
Jules Bordet Institute
Case Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Institute of Oncology Ljubljana
Pfizer
West Virginia University
Replimune Inc.
Institute of Oncology Ljubljana
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Florida
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana
Dana-Farber Cancer Institute
Regeneron Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute